Dr. Kevin Duane Graber, MD

Dr. Graber practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Graber's NPI, 1306898937, was assigned on May 16, 2006. Dr. Graber graduated from Indiana University School Of Medicine in 1992. Dr. Graber holds California license G79141.

Dr. Graber's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Graber's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Graber is also affiliated with Santa Clara Valley Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Graber to 2 more hospitals and 1 medical group, each named with a free account. Dr. Graber's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Graber practices, 4 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Graber's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Graber is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Graber is licensed in California.

Dmand AI lists encephalopathy, epilepsy, lower back pain, mobility impairment and seizures among the conditions Dr. Graber treats.

CMS data shows 478 Medicare services from Dr. Graber across 8 procedure codes in 2024, for 290 Medicare patients. Medicare paid $66,707 for them.

CMS counts 290 Medicare patients who saw Dr. Graber in 2024. The largest group is under 65, with 109 patients. 64% of them have high blood pressure, and 61% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Graber's median patient age at 48, with 51% women.

In 2024, Dr. Graber wrote 3,273 Medicare Part D claims for 219 patients. 82% of them were for generic drugs. CMS names the drug for 3,106 of them, across 42 drugs with 11 or more claims each, at $1,344,661 in total drug cost. In 2023, CMS named 2,343 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Graber for performance year 2024, reported as part of a group. Dr. Graber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Graber as offering telehealth.

Dmand AI links 18 papers to Dr. Graber, published from 2007 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Electroencephalography, Epilepsy and Brain Injuries. Dr. Graber has published most often in Epilepsia. Dr. Graber's most frequent co-authors are David Allan Prince, MD, Robert Scott Fisher, MD and Kimford Jay Meador, MD.

CMS Open Payments shows 7 general payments to Dr. Graber from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 76% of the total. Neuropace, Inc. paid the most, $218.

Dr. Graber graduated from Indiana University School Of Medicine in 1992.

Dr. Graber is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.